https://menafn.com/1108508210/Zymeworks-Provides-Corporate-Update-AndReports-Second-Quarter-2024-Financial-Results
Zymeworks Provides Corporate Update And Reports Second Quarter 2024 Financial Results
second quarterfinancial resultszymeworksprovidescorporate
https://www.lumiraventures.com/news/zymeworks-appoints-kathy-odriscroll-to-chief-people-officer/
Zymeworks Appoints Kathy O'Driscroll to Chief People Officer - Lumira Ventures | Venture Capital...
Apr 19, 2024 - VANCOUVER, British Columbia — Zymeworks Inc. (NYSE: ZYME), a clinical-stage biopharmaceutical company developing multifunctional therapeutics, today announced...
chief people officerventure capitalzymeworksappointskathy
https://www.onvista.de/aktien/ZYMEWORKS-Aktie-US98985Y1082
Zymeworks Aktie • A3DSSN • US98985Y1082 • onvista
zymeworksaktie
https://www.thehomebuyerpost.com/article/945771490-zymeworks-announces-updated-2026-financial-guidance-and-final-transaction-details-following-theravance-biopharma-acquisition
Zymeworks Announces Updated 2026 Financial Guidance and Final Transaction Details Following...
The Home Buyer Post is an online news publication focusing on real estate: Get your daily news on real estate
transaction detailszymeworksannouncesupdatedfinancial
https://www.technologyjournalnepal.com/article/919683476-zymeworks-presents-new-phase-1-data-for-folate-receptor-alpha-targeting-adc-zw191-at-esmo-gynaecological-cancers-congress-2026
Zymeworks Presents New Phase 1 Data for Folate Receptor Alpha-Targeting ADC ZW191 at ESMO...
folate receptor alphazymeworkspresentsnewphase
https://innovativetargeting.com/partner/zymeworks/
zymeworks – Innovative Targeting Solutions
ITS is a technology company that empowers its partners to unlock the full, transformational potential of biologics to improve human health.
zymeworksinnovativetargetingsolutions
https://www.lumiraventures.com/news/lota-zoth-chair-of-zymeworks-board-of-directors/
Lota Zoth Succeeds Nick Bedford as Chair of Zymeworks' Board of Directors - Lumira Ventures |...
Apr 19, 2024 - VANCOUVER, British Columbia — Zymeworks Inc. (NYSE/TSX: ZYME), a clinical-stage biopharmaceutical company developing multifunctional biotherapeutics, announced...
lotasucceedsnickbedfordchair
https://thnews.marketminute.com/quote/NQ:ZYME
Zymeworks Inc. - Common Stock (ZYME) Stock Price, News, Quote & History | Times-Herald
The current price of Zymeworks Inc. - Common Stock (ZYME) is 24.86 — it has gone down by -0.21 (-0.84%) today. Zymeworks Inc is a biotechnology company that...
common stocktimes heraldzymeworksincprice
Sponsored https://www.xlovecam.com/prm03/textlink?id_affilie=26457&p=online&tri=10
Best Live Sex Cam Shows with Free Live Chat | XLoveCam
Watch thousands of cam girls get naked on XLoveCam.
https://www.irishentertainmentdispatch.com/article/945771490-zymeworks-announces-updated-2026-financial-guidance-and-final-transaction-details-following-theravance-biopharma-acquisition
Zymeworks Announces Updated 2026 Financial Guidance and Final Transaction Details Following...
transaction detailszymeworksannouncesupdatedfinancial
https://newsstreetdaily.com/zymeworks-ceo-details-zanidatamab-approval-and-growth-strate/
Zymeworks CEO Discusses Zanidatamab Approval and Strategy
Zymeworks CEO Kenneth Galbraith shares updates on zanidatamab's FDA approval and the company's growth strategy, including its ADC platform and recent acquisitio
zymeworksceodiscusseszanidatamabapproval
https://www.venturecapitaljournal.com/zymeworks-raises-c35-million/
Zymeworks Raises C$3.5 Million
Apr 7, 2020 - Zymeworks Inc., a Vancouver-based computational biotech company, has raised C$3.5 million in new VC funding from firms like CTI Life Sciences Fund. No...
zymeworksraisesmillion
https://altindex.com/ticker/zyme/earnings
Zymeworks (ZYME) Earnings: Revenue, EPS & Earnings Date 2026 | AltIndex
Zymeworks (ZYME) reported Q2 '25 revenue of $49M (+153.2% YoY). See earnings history, EPS trends, beat/miss vs. estimates. Updated as results are reported.
zymeworksearningsrevenueepsdate
https://www.theeuropesun.com/article/945771490-zymeworks-announces-updated-2026-financial-guidance-and-final-transaction-details-following-theravance-biopharma-acquisition
Zymeworks Announces Updated 2026 Financial Guidance and Final Transaction Details Following...
The Europe Sun is an online news publication focusing on the Europe: The most trusted news from Europe
transaction detailszymeworksannouncesupdatedfinancial
https://www.mauritiushealthcaredaily.com/article/871954397-zymeworks-announces-participation-in-upcoming-conferences
Zymeworks Announces Participation in Upcoming Conferences | Mauritius Healthcare Daily
upcoming conferenceszymeworksannouncesparticipationmauritius
https://getbiobrief.com/story/zymeworks-theravance-acquisition-bio
Zymeworks Buys Theravance, Adds 3 Key Assets | GetBioBrief
Sep 24, 2026 - Zymeworks completed its Theravance Biopharma acquisition, adding YUPELRI, Ziihera, and pasritamig to its portfolio. Investor call Sept. 28 will cover final...
zymeworksbuysaddskeyassets